Have your own idea? Try our Stock Screener
Swiss (SMI) Biotech Industry Analysis
UpdatedAug 28, 2025
DataAggregated Company Financials
Companies5
- 7D-4.6%
- 3M0.9%
- 1Y27.3%
- YTD7.2%
Over the last 7 days, the Biotech industry has dropped 6.1%, driven by Kuros Biosciences declining 7.8%. In contrast, Idorsia has gained 8.2%. Over the past 12 months, the industry was up 29%. As for the next few years, earnings are expected to grow by 34% per annum.
Industry Valuation and Performance
Has the Swiss Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 28 Aug 2025 | CHF 1.9b | CHF 383.4m | -CHF 57,057,000.00 | 7.9x | -32.7x | 4.9x |
| Sat, 26 Jul 2025 | CHF 2.1b | CHF 333.9m | -CHF 44,705,000.00 | 9x | -47.7x | 6.4x |
| Mon, 23 Jun 2025 | CHF 1.9b | CHF 333.9m | -CHF 44,705,000.00 | 7.7x | -41.7x | 5.6x |
| Wed, 21 May 2025 | CHF 1.8b | CHF 333.9m | -CHF 44,705,000.00 | 7.1x | -40.7x | 5.5x |
| Fri, 18 Apr 2025 | CHF 1.6b | CHF 411.1m | CHF 65.6m | 4.7x | 24.8x | 4x |
| Sun, 16 Mar 2025 | CHF 1.7b | CHF 409.3m | -CHF 35,110,868.00 | 5.2x | -47.8x | 4.1x |
| Tue, 11 Feb 2025 | CHF 1.9b | CHF 330.3m | -CHF 75,131,868.00 | 3.3x | -26x | 5.9x |
| Thu, 09 Jan 2025 | CHF 1.9b | CHF 330.3m | -CHF 75,131,868.00 | 2.7x | -25.1x | 5.7x |
| Sat, 07 Dec 2024 | CHF 1.6b | CHF 330.9m | -CHF 87,805,465.00 | 1.5x | -17.8x | 4.7x |
| Mon, 04 Nov 2024 | CHF 1.9b | CHF 331.2m | -CHF 86,988,629.00 | 1.7x | -22.1x | 5.8x |
| Wed, 02 Oct 2024 | CHF 1.5b | CHF 333.1m | -CHF 79,869,873.00 | 1.8x | -18.8x | 4.5x |
| Fri, 30 Aug 2024 | CHF 1.4b | CHF 320.8m | -CHF 141,103,264.00 | 1.9x | -10.1x | 4.5x |
| Sun, 28 Jul 2024 | CHF 774.2m | CHF 151.7m | -CHF 146,197,264.00 | 1.6x | -5.3x | 5.1x |
| Tue, 25 Jun 2024 | CHF 771.9m | CHF 151.7m | -CHF 146,197,264.00 | 1.5x | -5.3x | 5.1x |
| Thu, 23 May 2024 | CHF 540.3m | CHF 170.4m | -CHF 131,481,799.34 | 1x | -4.1x | 3.2x |
| Sat, 20 Apr 2024 | CHF 430.2m | CHF 67.2m | -CHF 172,317,273.44 | 0.08x | -2.5x | 6.4x |
| Mon, 18 Mar 2024 | CHF 341.9m | CHF 67.0m | -CHF 173,340,900.02 | 0.3x | -2x | 5.1x |
| Wed, 14 Feb 2024 | CHF 380.4m | CHF 55.6m | -CHF 173,179,321.10 | 1x | -2.2x | 6.8x |
| Fri, 12 Jan 2024 | CHF 339.6m | CHF 317.4m | -CHF 176,081,171.00 | 0.6x | -1.9x | 1.1x |
| Sun, 10 Dec 2023 | CHF 348.6m | CHF 318.0m | -CHF 209,120,197.00 | n/a | -1.7x | 1.1x |
| Tue, 07 Nov 2023 | CHF 285.7m | CHF 318.4m | -CHF 211,122,883.00 | n/a | -1.4x | 0.9x |
| Thu, 05 Oct 2023 | CHF 253.3m | CHF 318.6m | -CHF 213,621,390.00 | n/a | -1.2x | 0.8x |
| Sat, 02 Sep 2023 | CHF 317.3m | CHF 318.5m | -CHF 188,737,917.00 | n/a | -1.7x | 1x |
| Mon, 31 Jul 2023 | CHF 415.5m | CHF 322.5m | -CHF 179,935,255.00 | n/a | -2.3x | 1.3x |
| Wed, 28 Jun 2023 | CHF 303.4m | CHF 330.7m | -CHF 180,755,653.00 | n/a | -1.7x | 0.9x |
| Fri, 26 May 2023 | CHF 335.0m | CHF 332.9m | -CHF 183,398,311.00 | n/a | -1.8x | 1x |
| Sun, 23 Apr 2023 | CHF 430.1m | CHF 480.7m | CHF 8.2m | 1.6x | 52.5x | 0.9x |
| Tue, 21 Mar 2023 | CHF 428.0m | CHF 497.1m | CHF 11.5m | 1.5x | 37.1x | 0.9x |
| Thu, 16 Feb 2023 | CHF 1.1b | CHF 493.4m | CHF 14.5m | 1.7x | 74.3x | 2.2x |
| Sat, 14 Jan 2023 | CHF 512.3m | CHF 493.4m | CHF 14.5m | 1.7x | 35.3x | 1x |
| Mon, 12 Dec 2022 | CHF 508.7m | CHF 493.4m | CHF 14.5m | 1.8x | 35.1x | 1x |
| Wed, 09 Nov 2022 | CHF 521.2m | CHF 506.8m | CHF 14.9m | 1.7x | 35x | 1x |
| Fri, 07 Oct 2022 | CHF 526.2m | CHF 507.3m | CHF 15.9m | 2x | 33.1x | 1x |
| Sun, 04 Sep 2022 | CHF 510.4m | CHF 501.1m | CHF 36.7m | 1.7x | 13.9x | 1x |
Price to Earnings Ratio
13.9x
Current Industry PE
- Investors are optimistic on the Swiss Biotechs industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 3.2x is lower than the industry's current PS ratio of 4.9x.
Past Earnings Growth
- Total earnings for the Biotechs industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 8.5% per year, which is driving profits down.
Industry Trends
Which industries have driven the changes within the Swiss Healthcare industry?
| CH Market | -0.56% | |
| Healthcare | 0.057% | |
| Biotech | -4.59% | |
| Biotech | -4.59% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| IDIA Idorsia | CHF 2.70 | 8.2% +CHF 41.8m | 22.4% | PS2.5x | |
| MOLN Molecular Partners | CHF 2.98 | 2.1% +CHF 14.0m | -43.9% | PS163.4x |
